Oncogene Cancer Research
@OncogeneCancer
Followers
940
Following
6K
Media
214
Statuses
3K
🔬 Research. Empowerment. Advocacy. Patients & families improving #LCSM outcomes via education, support & cutting-edge research
London, England
Joined May 2023
RT @Yvonne_Diaz_: Grateful to be on the board of @ALKPositiveinc & a co-founder of @OncogeneCancer w @Janclarkgirls. Also to collaborate w….
0
6
0
RT @EGFRResisters: Extended survival in a patient with leptomeningeal disease related to EGFR exon 19 deletion metastatic non-small cell lu….
0
14
0
We’ve launched the Patient Voices Podcast: Stories & Hope in Lung Cancer!. Our first episode features Kathrin, diagnosed at 44 w stage 4 ALK+ #lungcancer. She shares her journey, from unusual symptoms to treatment & coping strategies. 🎥 Part 1 👉 #LCSM
0
8
16
Being diagnosed w #cancer shouldn’t mean losing your rights at work. This session w solicitor Colin Davidson @ColeKhan_Law, brought to you w @EgfrUk & @Roy_Castle_Lung , covers how UK law protects you after a #lungcancer diagnosis. 🎥 Watch here: #LCSM
1
5
12
RT @EGFRResisters: WEBINAR ALERT: “Although it’s challenging to quantify the rate of leptomeningeal spread in cancers, some studies have sh….
0
2
0
RT @DrJNaidoo: #ASCOSNO25 .Superb talk by @tmprowell @US_FDA on the Regulatory Perspectives on including patients with CNS disease in clini….
0
13
0
RT @YoungLungCancer: ✨Share to spread the word .✨Lung cancer is affecting young people .✨The face of lung cancer is changing, and our awar….
0
16
0
How do we select the best 2L therapy for advanced EGFR‑mutant NSCLC after osimertinib?. Dr. @JuliaRotow outlines options by resistance mechanism, including the emerging amivantamab + lazertinib combo. Personalized strategies matter. #LCSM Via @ASCO.
cancertherapyadvisor.com
From May 30 to June 3, 2025, the American Society of Clinical Oncology (ASCO) Annual Meeting presented treatment advances for patients with non-small cell lung cancer (NSCLC). In this article, Julia...
1
4
15
RT @Cracking_Cancer: Cracking cancer would like to announce what is formally the cutest collaboration with @YoungLungCancer. Fitting given….
0
5
0
RT @IASLC: Zongertinib is now FDA approved for HER2+ NSCLC, but where does it fit in care?. On #LungCancerConsidered, @NarjustFlorezMD talk….
0
8
0
Surgery isn’t usually offered for stage 4 #lungcancer. Steve, diagnosed w stage 4 ALK+ in 2020, believed it could help prevent resistance. After targeted therapy shrank his tumour, he fought for surgery & got it. Read his story + our patient info: .#LCSM
0
6
16
RT @StephenVLiu: Comparison of EGFR NSCLC transformed to #SCLC vs de novo SCLC @LungCaJournal. OS shorter with transformed SCLC esp with hi….
lungcancerjournal.info
Small-cell lung cancer (SCLC) comprises 13–15 % of all lung cancer cases [1,2]. Due to its aggressive nature and early metastasis, two-thirds of the patients are initially diagnosed with extensive-...
0
31
0
RT @Exon20Group: Hearty congratulations to Dr. John Heymach and colleagues at @MDAndersonNews on their zongertinib triumph.
0
2
0
RT @Yvonne_Diaz_: Survival rates for the deadliest cancers – including lung – are barely improving. “The gap between the best & worst surv….
0
13
0
RT @Exon20Group: We all know that patients should not be on the chemo doublet + IO anyway--they should be on the gold standard, first-line….
0
5
0
RT @oncodaily: Oncogene Cancer Research - Kick Off Lung Cancer Awareness Month with the Oncogene Charity Ball .@OncogeneCancer . https://t.….
0
1
0
Big news for people w HER2+ #lungcancer. The FDA has granted accelerated approval to zongertinib — the first oral targeted therapy for advanced HER2+ NSCLC.👏👏. Hope powered by research, made possible by patients, scientists & advocates. 💙. via @onclive.
onclive.com
The FDA granted accelerated approval to zongertinib for pretreated, unresectable or metastatic non–small cell lung cancer harboring HER2 mutations.
0
6
16
RT @Exon20Group: Hooray! Our #HER2Warriors are thrilled. #zongertinib is approved for #NSCLC #HER2 TKD activating mutations! Congratulatio….
0
4
0
New research links high sucralose intake to reduced immunotherapy response in #lungcancer. Changes in gut bacteria lower arginine - key for T-cell function. Arginine supplements may help reverse it. đź”— #LCSM.
reuters.com
In patients with melanoma or non-small cell lung cancer, consuming high levels of the artificial sweetener sucralose contributes to diminished responses to immunotherapy and poorer survival, resear...
0
3
6